EPCO-24 Interrogating transcriptional dysregulation and dependency in medulloblastoma
Abstract
Medulloblastoma (MB) is a highly malignant pediatric cerebellar tumor comprising molecularly and clinically distinct subgroups. Group 3 and Group 4 MBs are believed to arise from overlapping progenitor populations within the developing rhombic lip (RL), when neuronal differentiation is stalled secondary to somatic driver events. Genetic alterations predicted to perturb transcription factor (TF) activity are pervasive in Groups 3 and 4 MB, suggesting that dysregulated gene regulatory programs drive MB pathogenesis. However, tumor-specific transcriptional signatures provoking and sustaining tumorigenesis remain poorly understood. Herein, we leveraged single-cell multiome datasets of MB and the developing human cerebellum to resolve gene expression programs and associated TF activity underlying malignancy in Groups 3 and 4 MB. Comparative analysis of MB transcriptomes and accessible chromatin landscapes with their cerebellar counterparts in the developing RL revealed profound disruption of neurogenic transcriptional networks, including master TFs such as OTX2 and NFIB. Genome-wide in vitro CRISPR screens further indicated that many of these TFs represent MB-selective growth dependencies. CRISPR-mediated inhibition and targeted protein degradation validated prioritized TFs as strong dependencies in Group 3 MB cell lines in vitro. Ongoing studies are focused on evaluating dysregulated transcriptional circuitry as a tumor-maintenance vulnerability in physiologically relevant contexts through in vivo CRISPR screens in Group 3 and Group 4 MB patient-derived xenograft models and investigating the molecular mechanisms governing TF dysregulation and dependency. Together, these studies aim to uncover actionable transcriptional vulnerabilities and provide a foundation for the development of mechanism-driven targeted therapies for high-risk MB subgroups.